Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
Masaki MiyazawaHajime TakatoriTetsuro ShimakamiKazunori KawaguchiKazuya KitamuraKuniaki AraiKoichiro MatsudaTaku SanadaTakeshi UrabeKatsuhisa InamuraTakashi KagayaHideki MizunoUichiro FuchizakiTaro YamashitaYoshio SakaiTatsuya YamashitaEishiro MizukoshiMasao HondaShuichi KanekoPublished in: PloS one (2017)
It was difficult to predict relapse of AIP based on clinical parameters before beginning CST. Relapse was likely to occur within 3 years after the beginning of CST and maintenance of CST for at least 3 years reduced the risk of relapse. The early initiation of CST for AIP with impaired glucose tolerance is desirable because pre-existing DM is refractory to CST.